8 completed, 3 terminated. 9 Phase 3, 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 9 | Completed 6, Terminated 3 |
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow cholebine: new trials by email Literature Review of cholebine trials Research Report on cholebine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Drug-Drug Interaction Study to Evaluate the Effect of Colestilan on the Pharmacokinetics of Single Doses of Candesartan Cilexetil in Healthy Subjects colestilan, candesartan - Hyperphosphatemia, Chronic Kidney Disease | Phase 1 | Completed | Tanabe Pharma Corporation | 18 | 2013-10-01 | 2026-01-07 |
| Long-term Extension Study of MCI-196 colestilan, CBPB - Chronic Kidney Disease, Dialysis | Phase 3 | Terminated | Tanabe Pharma Corporation | 6 | 2013-08-01 | 2015-05-27 |
| Safety and Tolerability Study of MCI-196 colestilan - Chronic Kidney Disease, Not on Dialysis | Phase 3 | Terminated | Tanabe Pharma Corporation | 4 | 2013-08-01 | 2015-05-27 |
| Efficacy and Safety Study of MCI-196 Versus Simvastatin for Dyslipidaemia in Chronic Kidney Disease (CKD) Subjects on Dialysis MCI-196, Placebo of Simvastatin, Simvastatin - Chronic Kidney Disease | Phase 3 | Completed | Tanabe Pharma Corporation | 260 | 2009-03-01 | 2026-01-07 |
| Study of MCI-196 in Chronic Kidney Disease Stage V Subjects on Dialysis With Hyperphosphatemia MCI-196 - Chronic Kidney Disease, Dialysis | Phase 3 | Completed | Tanabe Pharma Corporation | 116 | 2008-12-01 | 2026-01-08 |
| A Study of MCI-196 in Chronic Kidney Disease Subjects on Dialysis With Hyperphosphatemia and Dyslipidaemia MCI-196, Placebo - Chronic Kidney Disease, Dialysis | Phase 3 | Completed | Tanabe Pharma Corporation | 642 | 2007-12-01 | 2026-01-08 |
| A Study of MCI-196 in Chronic Kidney Disease Stage V Subjects on Dialysis With Hyperphosphatemia MCI-196, Another Phosphate binder (Sevelamer) - Chronic Kidney Disease, Dialysis | Phase 3 | Completed | Tanabe Pharma Corporation | 632 | 2007-11-01 | 2026-01-07 |
| A Phase 3, Randomized, Double Blind, Placebo-Controlled, Multi-Center, Withdrawal Study of MCI-196 in CKD on Dialysis With Hyperphosphatemia MCI-196, Placebo - Chronic Kidney Disease, Dialysis | Phase 3 | Completed | Tanabe Pharma Corporation | 245 | 2007-09-01 | 2026-01-08 |
| A Phase III, Multicentre, Double-Blind, Placebo-Controlled Withdrawal Study in Patients With Hyperphosphatemia MCI-196 (Colestilan(INN), Colestimide(JAN), CHOLEBINE®), Placebo, Another phosphate binder (Sevelamer) - Chronic Kidney Disease, Hyperphosphatemia | Phase 3 | Completed | Tanabe Pharma Corporation | 336 | 2007-06-01 | 2026-01-08 |
| A Phase III, Multi-Centre, Randomised, Placebo-Controlled Study in Combination With Ca-based P Binders in Patients With Hyperphosphatemia MCI-196(colestilan(INN), Colestimide(JAN), CHOLEBINE®), Placebo - Chronic Kidney Disease, Dialysis | Phase 3 | Terminated | Tanabe Pharma Corporation | 6 | 2007-05-01 | 2011-11-15 |
| Efficacy and Safety Study of MCI-196 in Patients With Type 2 Diabetes MCI-196, Placebo of MCI-196 Tablet - Type 2 Diabetes | Phase 2 | Completed | Tanabe Pharma Corporation | 183 | 2005-10-01 | 2026-01-06 |
Renal Insufficiency, Chronic (10) · Hyperphosphatemia (9) · Dyslipidemias (2) · Diabetes Mellitus, Type 2 (1)
Tanabe Pharma Corporation (11)
United Kingdom (6) · Italy (5) · Poland (4) · Czechia (3) · France (3) · Germany (3) · Hungary (3) · Malaysia (3) · North Macedonia (3) · Serbia (3) · South Africa (3) · Spain (3) · Austria (2) · Russia (2) · Ukraine (2)
Jim Bush, Dr (1) · Kazuoki Kondo, MD (1)